Table 2. Association of mean C-IMT and frequency of carotid plaque with NAFLD.
Without fatty liver | With NAFLD | p-value | |
---|---|---|---|
n | 599 | 123 | |
C-IMT | |||
Unadjusted | 0.69 ± 0.18 | 0.81 ± 0.25 | <0.001 |
Multiple adjusted association | |||
Model 1 | 0.700 ± 0.007 | 0.816 ± 0.018 | <0.001 |
Model 2 | 0.701 ± 0.009 | 0.815 ± 0.011 | <0.001 |
Model 3 | 0.704 ± 0.007 | 0.790 ± 0.019 | <0.001 |
Carotid plaque, % | |||
Unadjusted | 1 | 1.994 (1.218–3.264) | 0.006 |
Multiple adjusted association | |||
Model 1 | 1 | 1.683 (0.819–3.459) | 0.157 |
Model 2 | 1 | 1.670 (0.812–3.434) | 0.163 |
Model 3 | 1 | 1.021 (0.450–2.317) | 0.960 |
Data are expressed as mean ± SE and odds ratios ± 95% CI as assessed by an analysis of covariance or multivariate logistic regression analysis. The models adjusted as follows: model 1: Adjusted for age, sex, BMI, waist circumference, systolic blood pressure, diastolic blood pressure, TC, TG, LDL cholesterol, HDL cholesterol; model 2: as model 1, plus further adjustment for presence of the metabolic syndrome (as categorical variable); model 3: as model 2 plus ALT, AST, GGT, hsCRP, and medication use (anti-hypertensive, and lipid-lowering).